Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05784012 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05784012
- Sponsor
- Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2027-03-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.